Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Pentadecapeptide BPC 157 and the central nervous system (CROSBI ID 315704)

Prilog u časopisu | pregledni rad (stručni) | međunarodna recenzija

Vukojević, Jakša ; Milavić, Marija ; Perović, Darko ; Ilić, Spomenko ; Čilić, Zemba, Andrea ; Đuran, Nataša ; Štrbe, Sanja ; Zoričić, Zoran ; Filipčić, Igor ; Brečić, Petrana et al. Pentadecapeptide BPC 157 and the central nervous system // Neural Regeneration Research, 17 (2022), 3; 482-487. doi: 10.4103/1673-5374.320969

Podaci o odgovornosti

Vukojević, Jakša ; Milavić, Marija ; Perović, Darko ; Ilić, Spomenko ; Čilić, Zemba, Andrea ; Đuran, Nataša ; Štrbe, Sanja ; Zoričić, Zoran ; Filipčić, Igor ; Brečić, Petrana ; Seiwerth, Sven ; Sikirić, Predrag

engleski

Pentadecapeptide BPC 157 and the central nervous system

We reviewed the pleiotropic beneficial effects of the stable gastric pentadecapeptide BPC 157, three very recent demonstrations that may be essential in the gut-brain and brain-gut axis operation, and therapy application in the central nervous system disorders, in particular. Firstly, given in the reperfusion, BPC 157 counteracted bilateral clamping of the common carotid arteries-induced stroke, sustained brain neuronal damages were resolved in rats as well as disturbed memory, locomotion, and coordination. This therapy effect supports particular gene expression in hippocampal tissues that appeared in BPC 157-treated rats. Secondly, there are L-NG-nitro arginine methyl ester (L-NAME)- and haloperidol-induced catalepsy as well as the rat acute and chronic models of ‘positive-like’ schizophrenia symptoms, that BPC 157 counteracted, and resolved the complex relationship of the nitric oxide-system with amphetamine and apomorphine (dopamine agents application), MK-801 (non-competitive antagonist of the N-methyl-D-aspartate receptor) and chronic methamphetamine administration (to induce sensitivity). Thirdly, after rat spinal cord compression, there were advanced healing and functional recovery (counteracted tail paralysis). Likewise, in BPC 157 therapy, there is specific support for each of these topics: counteracted encephalopathies ; alleviated vascular occlusion disturbances (stroke) ; counteracted dopamine disturbances (dopamine receptors blockade, receptors super sensitivity development, or receptor activation, over-release, nigrostriatal damage, vesicles depletion), and nitric oxide- system disturbances (“L-NAME non-responsive, L- arginine responsive, ” and “L-NAME responsive, L- arginine responsive”) (schizophrenia therapy) ; inflammation reduction, nerve recovery in addition to alleviated hemostasis and vessels function after compression (spinal cord injury therapy). Thus, these disturbances may be all resolved within the same agent’s beneficial activity, i.e., the stable gastric pentadecapeptide BPC 157.

central nervous system ; cytoprotection ; injury ; nitric oxide system ; peptide ; regeneration

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

17 (3)

2022.

482-487

objavljeno

1673-5374

1876-7958

10.4103/1673-5374.320969

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost